In conclusion, our results demonstrated the molecular mechanism underlying the effect of LINC00470 on CML by reducing the PTEN stability via RNA methyltransferase METTL3, thus leading to the inhibition of cell autophagy while promoting chemoresistance in CML. The gene discussed is METTL3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.